Drug
NexoBrid
NexoBrid is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_3
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
2(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (100.0%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_3
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
NCT02278718
unknown
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
NCT04040660
completedphase_3
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns
NCT02148705
Clinical Trials (3)
Showing 3 of 3 trials
NCT02278718Phase 3
A Study to Evaluate the Efficacy and Safety of NexoBrid in Children With Thermal Burns Compared the Standard of Care
NCT04040660
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
NCT02148705Phase 3
A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3